M&B Engineering IPO: Should You Subscribe or Avoid? 10 Key Things You Must Know
Get the lowdown on the M&B Engineering IPO, including key facts, strengths, strategies, and risks to help you make an informed decision.
Get the lowdown on the M&B Engineering IPO, including key facts, strengths, strategies, and risks to help you make an informed decision.
In an exclusive interview, ICAI President Charanjot Singh Nanda shares his views on building a strong foundation for Indian firms to compete globally with the Big Four. Learn how identifying the right partners, upscaling technical capabilities, and maintaining transparency are crucial for success.
The Indian stock market is witnessing a consolidation phase ahead of major earnings announcements from tech giants. The Nifty is hovering around its all-time high, and investors are keenly awaiting the Q1 results to gauge the health of the economy.
Sterlite Technologies, a leading optical fibre and connectivity solutions provider, is aiming to achieve an EBITDA margin of 18-20% in FY26, driven by enhanced capacity utilisation and a focus on data centers.
Swiggy is set to announce its Q1 results, with analysts expecting strong revenue growth and narrowing losses. Here’s what to expect from the food delivery giant’s quarterly performance.
Ather Energy Ltd. receives ‘buy’ rating from HSBC and Nomura with target prices of Rs 450 and Rs 458, respectively. Is this EV stock a must-buy?
As Hindustan Unilever Ltd. prepares to announce its Q1 results, analysts predict subdued growth amidst a flat EBITDA over FY26. Will the company manage to buck the trend?
Get the latest analysis on Mazagon Dock Shipbuilders Ltd.’s Q1 results and why analysts are bullish on the stock, expecting up to 27% upside.
Laxmi India Finance Ltd has raised over Rs 75 crore from anchor investors ahead of its initial public offering (IPO). The NBFC player has allotted 47.79 lakh equity shares to 11 funds at Rs 158 apiece.
Citi Research has increased the price target for Torrent Pharmaceuticals Ltd. to Rs 4,380 from Rs 4,000, citing a healthy and in-line quarter and solid traction across the markets. The brokerage maintains a ‘buy’ rating for the firm.